Biomanufacturing Excellence Act of 2025

The Biomanufacturing Excellence Act of 2025 establishes a National Biopharmaceutical Manufacturing Center of Excellence under the National Institute of Standards and Technology (NIST). It directly affects U.S. biopharmaceutical manufacturers, research institutions, and workers by funding a competitive grant program to create a center focused on advancing biomanufacturing technologies. Key provisions include improving manufacturing processes, reducing reliance on foreign supply chains, supporting workforce training, and requiring annual progress reports to Congress. The bill authorizes $120 million for fiscal year 2026 to build facilities, conduct collaborative research, and develop training programs, with the center required to prioritize national security, health security, and economic security needs.